ALTO NEUROSCIENCE INC (ANRO) Stock Cash Flow
USA - New York Stock Exchange - NYSE:ANRO - US02157Q1094 - Common Stock
18.575 USD
+0.14 (+0.79%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.26M | -61.43M | -36.30M | -27.71M | -9.19M | |||
| Depreciation Amortization | 674.00K | 502.00K | 373.00K | 342.00K | 145.00K | |||
| Change In Working Capital | -1.97M | 4.06M | -698.00K | 4.58M | -572.00K | |||
| Interest Paid | 1.48M | 999.00K | N/A | N/A | N/A | |||
| Other non cash items | 10.28M | 9.45M | 3.18M | 2.40M | 352.00K | |||
| OPERATING CASH FLOW | -53.27M | -47.42M | -33.45M | -20.39M | -9.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -530.00K | -2.08M | -470.00K | -732.00K | -680.00K | |||
| INVESTING CASH FLOW | -530.00K | -2.08M | -470.00K | -732.00K | -680.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.22M | 1.25M | 0.00 | 9.82M | 0.00 | |||
| Stock Issued/Repurchased | 400.00K | 137.77M | 70.18M | 34.30M | 31.89M | |||
| Other Financing Activity | -683.00K | -3.33M | -2.05M | -341.00K | -205.00K | |||
| FINANCING CASH FLOW | 9.94M | 135.69M | 68.13M | 43.79M | 31.69M | |||
| Exchange Rate Effect | -23.00K | -11.00K | -8.00K | -24.00K | -50.00K | |||
| CHANGE IN CASH | -43.88M | 86.18M | 34.20M | 22.64M | 21.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.27M | -47.42M | -33.45M | -20.39M | -9.26M | |||
| Capital Expenditure | -530.00K | -2.08M | -470.00K | -732.00K | -680.00K | |||
| FREE CASH FLOW | -53.80M | -49.50M | -33.92M | -21.13M | -9.94M | |||
All data in USD